104 related articles for article (PubMed ID: 38808639)
1. Ototoxicity in Immune Checkpoint Inhibitors Therapy.
Wierzbicka M; Mielnik J; Kołodziejska E; Klimza H; Szyfter W; Radomska K
Otolaryngol Pol; 2024 Jun; 78(3):1-5. PubMed ID: 38808639
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.
Guven DC; Erul E; Kaygusuz Y; Akagunduz B; Kilickap S; De Luca R; Rizzo A
Support Care Cancer; 2023 Oct; 31(12):624. PubMed ID: 37819422
[TBL] [Abstract][Full Text] [Related]
3. Management of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Intratympanic Platelet-Rich Plasma (PRP) Versus Intratympanic Steroid Injections: A Cross-Sectional Study.
Shawky M
Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808642
[TBL] [Abstract][Full Text] [Related]
4. The management of sudden sensorineural hearing loss during COVID-19 pandemic.
Rozbicki P; Usowski J; Siewiera J; Jurkiewicz D
Otolaryngol Pol; 2023 Apr; 77(3):7-11. PubMed ID: 37772322
[TBL] [Abstract][Full Text] [Related]
5. Piezoelectric bone conduction hearing implant Osia® - audiological and quality of life benefits.
Marszał J; Gibasiewicz R; Błaszczyk M; Gawłowska M; Gawęcki W
Otolaryngol Pol; 2021 Jun; 75(6):11-22. PubMed ID: 35175219
[TBL] [Abstract][Full Text] [Related]
6. Patogenesis of tinnitus in patients with post-COVID syndrome - preliminary report.
Rozbicki P; Krzywdzińska S; Kaczmarczyk M; Usowski J; Lubas A; Jurkiewicz D
Otolaryngol Pol; 2023 Oct; 77(6):18-22. PubMed ID: 38038406
[TBL] [Abstract][Full Text] [Related]
7. Otosclerosis - analysis of factors influencing the improvement of hearing after surgical treatment.
Wiatr A; Szpak K; Składzień J; Wiatr M
Otolaryngol Pol; 2022 Apr; 76(3):1-6. PubMed ID: 35796394
[TBL] [Abstract][Full Text] [Related]
8. The Importance of Screening for Hearing Loss in the Elderly.
Kovalová M; Mrázková E; Škerková M; Čada Z; Janoutová J
Otolaryngol Pol; 2021 Dec; 76(3):32-38. PubMed ID: 35796396
[TBL] [Abstract][Full Text] [Related]
9. Stability of ABR Wave V Threshold in Early Hearing Diagnostics in Children from Selected Groups at Risk of Congenital Hearing Loss.
Kocoń S; Skórkiewicz K; Stręk P; Ziarno R; Składzień J; Hartwich P; Tomik J
Otolaryngol Pol; 2020 Jul; 75(1):7-15. PubMed ID: 33724222
[TBL] [Abstract][Full Text] [Related]
10. Conductive hearing loss after surgical treatment of otosclerosis - long-term observations.
Szyfter W; Gawęcki W; Bartochowska A; Balcerowiak A; Pietraszek M; Wierzbicka M
Otolaryngol Pol; 2020 Dec; 75(1):1-6. PubMed ID: 33724223
[TBL] [Abstract][Full Text] [Related]
11. Modification of skin incision for Baha Attract System Implantations.
Ślęzak A; Wróbel MJ
Otolaryngol Pol; 2024 Jun; 78(3):1-5. PubMed ID: 38808636
[TBL] [Abstract][Full Text] [Related]
12. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
Phillips OR; Baguley DM; Pearson SE; Akeroyd MA
J Cancer Surviv; 2023 Feb; 17(1):40-58. PubMed ID: 36637633
[TBL] [Abstract][Full Text] [Related]
13. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S
Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma.
Rosner S; Agrawal Y; Sun DQ; Aygun N; Schollenberger MD; Lipson E; Naidoo J
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335030
[TBL] [Abstract][Full Text] [Related]
15. Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
Ngamphaiboon N; Ithimakin S; Siripoon T; Sintawichai N; Sriuranpong V
BMC Cancer; 2021 Nov; 21(1):1275. PubMed ID: 34823493
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review.
Kovalová M; Gottfriedová N; Mrázková E; Janout V; Janoutová J
Otolaryngol Pol; 2024 Apr; 78(2):1-17. PubMed ID: 38623856
[TBL] [Abstract][Full Text] [Related]
17. Necrotizing fasciitis - two case reports and literature review.
Molasy B; Frydrych M
Pol Przegl Chir; 2023 Nov; 96(0):103-108. PubMed ID: 38348986
[TBL] [Abstract][Full Text] [Related]
18. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal and Systemic Interleukin-10 as Early Biomarkers for Colorectal Anastomotic Leakage Following Surgery in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Villegas-Coronado L; Villegas-Coronado K; Villegas Coronado D
Pol Przegl Chir; 2023 Nov; 96(0):135-142. PubMed ID: 38348991
[TBL] [Abstract][Full Text] [Related]
20. Detailed insight into transtympanic electrocochleography (TT-ECochG) and direct cochlear nerve action potential (CNAP) for intraoperative hearing monitoring in patients with vestibular schwannoma - methodology of measurements and interpretation of results.
Pobożny I; Lachowska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2020 Sep; 74(6):1-8. PubMed ID: 33408268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
